These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6745080)

  • 1. The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods.
    Sheiner LB
    Drug Metab Rev; 1984; 15(1-2):153-71. PubMed ID: 6745080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model.
    Steimer JL; Mallet A; Golmard JL; Boisvieux JF
    Drug Metab Rev; 1984; 15(1-2):265-92. PubMed ID: 6745083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experiences in the application of NONMEM to pharmacokinetic data analysis.
    Flühler H; Huber H; Widmer E; Brechbühler S
    Drug Metab Rev; 1984; 15(1-2):317-39. PubMed ID: 6547665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential model and experimental pharmacokinetic data.
    Sheiner LB; Beal SL
    J Pharmacokinet Biopharm; 1981 Oct; 9(5):635-51. PubMed ID: 7334463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data.
    Sheiner LB; Beal SL
    J Pharmacokinet Biopharm; 1980 Dec; 8(6):553-71. PubMed ID: 7229908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian approaches in pharmacokinetic decision making.
    Schumacher GE; Barr JT
    Clin Pharm; 1984; 3(5):525-30. PubMed ID: 6488735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Individualization of drug dosage by therapeutic monitoring in plasma and the application of pharmacokinetic principles].
    Klotz U
    J Clin Chem Clin Biochem; 1983 Nov; 21(11):649-58. PubMed ID: 6655441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetic data and parameter estimation based on their first two statistical moments.
    Beal SL
    Drug Metab Rev; 1984; 15(1-2):173-93. PubMed ID: 6745081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of population pharmacokinetic parameters using destructively obtained experimental data: a simulation study of the one-compartment open model.
    Lindstrom FT; Birkes DS
    Drug Metab Rev; 1984; 15(1-2):195-264. PubMed ID: 6745082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simulation studies of errors of parameter estimates in pharmacokinetics.
    Betzien G; Kaufmann B; Schneider B; Ritschel WA
    Arzneimittelforschung; 1985; 35(1):7-14. PubMed ID: 3838673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: routine clinical pharmacokinetic data.
    Sheiner LB; Beal SL
    J Pharmacokinet Biopharm; 1983 Jun; 11(3):303-19. PubMed ID: 6644555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of population pharmacokinetic approach to clinical evaluation of anticancer agents].
    Tanigawara Y
    Gan To Kagaku Ryoho; 2001 May; 28(5):711-21. PubMed ID: 11383224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic analysis of amikacin and validation on neonates using Monte Carlo method.
    Wang J; Liang WQ; Wu JJ; Pan CM
    Acta Pharmacol Sin; 2000 Oct; 21(10):954-60. PubMed ID: 11501052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
    Bolon-Larger M; Chamouard V; Bressolle F; Boulieu R
    Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of gentamicin in horses.
    Martín-Jiménez T; Papich MG; Riviere JE
    Am J Vet Res; 1998 Dec; 59(12):1589-98. PubMed ID: 9858412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target-mediated drug disposition model: approximations, identifiability of model parameters and applications to the population pharmacokinetic-pharmacodynamic modeling of biologics.
    Gibiansky L; Gibiansky E
    Expert Opin Drug Metab Toxicol; 2009 Jul; 5(7):803-12. PubMed ID: 19505189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating population kinetics.
    Beal SL; Sheiner LB
    Crit Rev Biomed Eng; 1982; 8(3):195-222. PubMed ID: 6754254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics: current requirements and future perspectives from a regulatory point of view.
    Shah RR
    Xenobiotica; 1993 Nov; 23(11):1159-93. PubMed ID: 8310705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative performance of different stochastic methods to simulate drug exposure and variability in a population.
    Tam VH; Kabbara S
    Diagn Microbiol Infect Dis; 2006 Oct; 56(2):185-8. PubMed ID: 16930922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.